CausalSentinel

Protein Dossier — CX3CL1 (Fractalkine)

MR feasibility tier: A — Published pQTL-MR estimates exist for this protein (retrieved below - not computed here).

1. Published MR estimates (retrieved, not computed)

Outcome beta se p method nSNP cis/trans coloc
Body mass index (BMI) 0.0465 0.0135 5.66e-04 Wald ratio 1 cis NA
Weight 0.0377 0.0119 0.00154 Wald ratio 1 cis NA
Fractured or broken bones in last 5 years 0.113 0.0376 0.00269 Wald ratio 1 cis NA
Diagnoses - main ICD10: I83 Varicose veins of lower extremities 0.202 0.0774 0.0091 Wald ratio 1 cis NA
Non-cancer illness code self-reported: hypertension 0.0565 0.0217 0.00928 Wald ratio 1 cis NA
Fractured bone site(s): Other bones 0.123 0.052 0.0182 Wald ratio 1 cis NA
Non-cancer illness code self-reported: uterine fibroids -0.38 0.165 0.021 Wald ratio 1 cis NA
Diagnoses - main ICD10: M23 Internal derangement of knee 0.171 0.0769 0.0259 Wald ratio 1 cis NA
Diagnoses - main ICD10: C50 Malignant neoplasm of breast 0.194 0.0875 0.0264 Wald ratio 1 cis NA
Eye problems or disorders: Glaucoma -0.358 0.166 0.0314 Wald ratio 1 cis NA
Vascular or heart problems diagnosed by doctor: Angina 0.138 0.0662 0.0377 Wald ratio 1 cis NA
Diagnoses - main ICD10: R10 Abdominal and pelvic pain 0.111 0.0585 0.0585 Wald ratio 1 cis NA
…and 62 more outcomes (see JSON)              

2. pQTL instrument availability (Tier-B probe)

Dataset Trait Author Year
prot-c-2827_23_2 Fractalkine/CX3CL-1 Suhre K 2019

3. GWAS Catalog results — traits with signal at this locus

28 association rows across 22 traits (25 genome-wide significant rows). Associations are loci, not causal claims; the mapped gene at a locus is not necessarily the effector gene.

Trait best p lead SNP n assoc study MR status
Circulating CX3CL1 levels (id: OID00552_OID20976) 4e-311 rs671623 2 GCST90859902 no MR -> candidate analysis
CX3CL1 protein levels 8e-248 rs781264602 2 GCST90468921 no MR -> candidate analysis
Circulating CX3CL1 levels (id: OID00806_OID20976) 4e-224 rs671623 2 GCST90860136 no MR -> candidate analysis
CX3CL1/EPHB6 protein level ratio 6e-147 rs170361 1 GCST90314324 no MR -> candidate analysis
CX3CL1/LAYN protein level ratio 5e-140 rs170361 1 GCST90314325 no MR -> candidate analysis
CCL17/CCL22 protein level ratio 3e-133 rs801506 1 GCST90313682 no MR -> candidate analysis
CCL17 protein levels 1e-113 rs8102 1 GCST90468569 no MR -> candidate analysis
CX3CL1 levels 3e-86 rs683544 1 GCST90012074 no MR -> candidate analysis
CCL17/CXCL3 protein level ratio 4e-70 rs62037082 1 GCST90313685 no MR -> candidate analysis
CCL17/CD69 protein level ratio 6e-70 rs62037082 1 GCST90313684 no MR -> candidate analysis
Fractalkine levels 1e-66 rs671623 3 GCST90274778 no MR -> candidate analysis
C-C motif chemokine 22 levels 2e-38 rs170364 1 GCST90246911 no MR -> candidate analysis
…and 10 more traits (see JSON)          

4. Phenome map — where this gene is a genetic locus, vs. where MR exists

No genetically-associated diseases retrieved from Open Targets.

5. Downstream annotation (druggability & safety preview)

Layer Result
ChEMBL druggability 1 known modulators (Fractalkine)
gnomAD constraint not available
GWAS Catalog 72 unique SNPs / 144 rows
ClinVar 121 records; 2 pathogenic in sample of 30
PharmGKB/ClinPGx no annotations

Caveats declared by the tools

Sources

Provenance